Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
15.11
-0.39 (-2.52%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Anika Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Anika Therapeutics stock have an average target of 22, with a low estimate of 20 and a high estimate of 24. The average target predicts an increase of 45.60% from the current stock price of 15.11.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Anika Therapeutics stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +32.36% | Mar 13, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $37 → $25 | Buy | Maintains | $37 → $25 | +65.45% | Nov 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +144.87% | Oct 22, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +144.87% | Aug 9, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $24 | Hold | Reiterates | $24 | +58.84% | May 29, 2024 |
Financial Forecast
Revenue This Year
116.79M
from 119.91M
Decreased by -2.60%
Revenue Next Year
126.72M
from 116.79M
Increased by 8.50%
EPS This Year
-0.36
from -3.83
EPS Next Year
0.23
from -0.36
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 121.8M | 131.3M |
| Avg | 116.8M | 126.7M |
| Low | 110.7M | 121.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 1.6% | 12.4% |
| Avg | -2.6% | 8.5% |
| Low | -7.6% | 3.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.26 | 0.89 | -0.29 |
| Avg | -0.36 | 0.23 | -0.29 |
| Low | -0.44 | -0.39 | -0.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.